Nicolas Madranges

636 total citations
11 papers, 81 citations indexed

About

Nicolas Madranges is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Nicolas Madranges has authored 11 papers receiving a total of 81 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 3 papers in Cancer Research. Recurrent topics in Nicolas Madranges's work include Advanced Breast Cancer Therapies (4 papers), Cancer Treatment and Pharmacology (4 papers) and Breast Cancer Treatment Studies (3 papers). Nicolas Madranges is often cited by papers focused on Advanced Breast Cancer Therapies (4 papers), Cancer Treatment and Pharmacology (4 papers) and Breast Cancer Treatment Studies (3 papers). Nicolas Madranges collaborates with scholars based in France and United States. Nicolas Madranges's co-authors include Marc Debled, L. Mauriac, M. Durand, Véronique Brouste, Anne Floquet, Caroline Streicher, C. Mertens, Nadine Houédé, Hervé Bonnefoi and Étienne Brain and has published in prestigious journals such as Cancer Research, British Journal of Cancer and Breast Cancer Research and Treatment.

In The Last Decade

Nicolas Madranges

9 papers receiving 78 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicolas Madranges France 7 69 39 22 15 13 11 81
C. Tosello Brazil 3 78 1.1× 24 0.6× 42 1.9× 6 0.4× 6 0.5× 10 96
Bronwyn D. Mixter United States 4 70 1.0× 34 0.9× 30 1.4× 18 1.2× 4 0.3× 5 100
Sandeep H. Mashru United States 4 71 1.0× 55 1.4× 21 1.0× 26 1.7× 11 0.8× 7 96
Željko Vojnović Croatia 4 102 1.5× 93 2.4× 18 0.8× 21 1.4× 17 1.3× 11 132
Nikola Vasev Croatia 3 100 1.4× 90 2.3× 15 0.7× 20 1.3× 17 1.3× 6 123
Lindsay A. Bernardo United States 3 47 0.7× 65 1.7× 16 0.7× 31 2.1× 9 0.7× 7 93
C. Lerchenmueller Germany 4 63 0.9× 33 0.8× 14 0.6× 8 0.5× 12 0.9× 7 79
Edward Y. Zhu United States 5 28 0.4× 26 0.7× 24 1.1× 16 1.1× 11 0.8× 13 73
Hayley McKenzie United Kingdom 5 56 0.8× 34 0.9× 15 0.7× 6 0.4× 7 0.5× 10 88
Laura Murillo Spain 5 48 0.7× 20 0.5× 20 0.9× 11 0.7× 4 0.3× 14 63

Countries citing papers authored by Nicolas Madranges

Since Specialization
Citations

This map shows the geographic impact of Nicolas Madranges's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Madranges with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Madranges more than expected).

Fields of papers citing papers by Nicolas Madranges

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Madranges. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Madranges. The network helps show where Nicolas Madranges may publish in the future.

Co-authorship network of co-authors of Nicolas Madranges

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas Madranges. A scholar is included among the top collaborators of Nicolas Madranges based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas Madranges. Nicolas Madranges is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Streicher, Caroline, et al.. (2020). Severe rhabdomyolysis induced by possible drug–drug interaction between Ribociclib and Simvastatin. Journal of Oncology Pharmacy Practice. 27(3). 722–726. 10 indexed citations
2.
Chakiba, Camille, L. Mignot, Nicolas Madranges, et al.. (2015). Efficacy and tolerance of everolimus in 123 consecutive advanced ER positive, HER2 negative breast cancer patients. A two center retrospective study. The Breast. 24(6). 718–722. 9 indexed citations
3.
Chakiba, Camille, L. Mignot, Nicolas Madranges, et al.. (2015). Abstract P5-19-26: Efficacy and tolerance of everolimus in 123 consecutive very advanced luminal breast cancer patients. A multicenter retrospective study. Cancer Research. 75(9_Supplement). P5–19.
4.
Baffert, Sandrine, Paul Cottu, Youlia Kirova, et al.. (2013). Treatment patterns, clinical outcomes and health care costs associated with her2-positive breast cancer with central nervous system metastases: a French multicentre observational study. BMC Health Services Research. 13(1). 456–456. 6 indexed citations
5.
6.
Toulmonde, Maud, Nicolas Madranges, Véronique Brouste, et al.. (2012). Docetaxel rechallenge after a first response in non-resistant metastatic breast cancer: significant activity with manageable toxicity. Breast Cancer Research and Treatment. 134(1). 325–332. 13 indexed citations
7.
Debled, Marc, Nicolas Madranges, C. Mertens, et al.. (2010). First-line chemotherapy for metastatic breast cancer in patients ≥75 years: A retrospective single-centre analysis. Critical Reviews in Oncology/Hematology. 80(1). 171–179. 17 indexed citations
8.
Debled, Marc, Nicolas Madranges, Anne Floquet, et al.. (2009). First-Line Capecitabine Monotherapy for Slowly Progressing Metastatic Breast Cancer: Do We Need Aggressive Treatment?. Oncology. 77(5). 318–327. 8 indexed citations
9.
10.
Debled, M., Nicolas Madranges, C. Mertens, et al.. (2008). Retrospective analysis of chemotherapy choices and overall survival according to treatment in 96 patients >75 years old with metastatic breast cancer. European Journal of Cancer Supplements. 6(7). 174–174. 5 indexed citations
11.
Debled, Marc, Nadine Houédé, Nicolas Madranges, et al.. (2007). Does chemotherapy-induced neutropaenia result in a postponement of adjuvant or neoadjuvant regimens in breast cancer patients? Results of a retrospective analysis. British Journal of Cancer. 97(12). 1642–1647. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. Tosello Breakdown of academic impact, for papers by Bronwyn D. Mixter Breakdown of academic impact, for papers by Sandeep H. Mashru Breakdown of academic impact, for papers by Željko Vojnović Breakdown of academic impact, for papers by Nikola Vasev Breakdown of academic impact, for papers by Lindsay A. Bernardo Breakdown of academic impact, for papers by C. Lerchenmueller Breakdown of academic impact, for papers by Edward Y. Zhu Breakdown of academic impact, for papers by Hayley McKenzie Breakdown of academic impact, for papers by Laura Murillo
Rankless by CCL
2026